Journal of Clinical and Aesthetic Dermatology

AUG 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link:

Contents of this Issue


Page 53 of 67

54 JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY august 2017 • volume 10 • number 8 r e v i e w surface pH, sebum content, and stratum corneum hydration with age and gender in a large chinese population. Skin Pharmacol Physiol. 2009;22:190–199. 10. wan mJ, su Xy, Zheng y, et al. seasonal variability in the biophysical properties of forehead skin in women in guangzhou city, china. Int J Dermatol. 2015;54:1319–1324. 11. roh m, Han m, kim d, chung k. sebum output as a factor contributing to the size of facial pores. Br J Dermatol. 2006;155:890–894. 12. sugiyama-nakagiri y, sugatak, Hachiya a, et al. ethnic diserences in the structural properties of facial skin. J Dermatol Sci. 2009;53:135–139. 13. Fritsch m, Orfanos cd, Zouboulis cc. sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116:793–800. 14. Zouboulis cc, Frimmel s, Ortmann J, et al. sebaceous glands. in: Hoath sB, maibach Hi, eds. Neonatal Skin: Structure and Function. 2nd ed. Basel: taylor and Francis; 2003:59–88. 15. Fluhr Jw, mao-Qiang m, Brown Be, et al. glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol. 2003;120:728–737. 16. lee d-y, yamasaki k, Zouboulis cc, et al. sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol. 2008;128:1863–1866. 17. Brand n, Petkovich m, krust a, et al. identification of a second human retinoic acid receptor. Nature. 1988;332:850–853. 18. Fisher gJ, talwar Hs, Xiao JH, et al. immunological identification and functional quantification of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem. 1994;269:20629–20635. 19. duell ea, astrom a, gritths ce, et al. Human skin levels of retinoic acid and cytochrome P-450- derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate rar-mediated transcription in vitro. J Clin Invest. 1992;4:1269–1274. 20. Baron Jm, Heise r, Blaner w, et al. retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005;125:143–153. 21. mills OH, marples rr, kligman am. acne vulgaris. Oral therapy with tetracycline and topical therapy with vitamin a. Arch Dermatol. 1972;106:200–203. 22. Zouboulis cc. sebaceous gland receptors. Dermatoendocrinol. 2009;1:77–80. 23. tsukada m, schroder m, roos tc, et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all- trans retinoic acid and brinding to retinoid acid receptors. J Invest Dermatol. 2000;115:321–327. 24. Zouboulis cc, korge B, akamatsu J, et al. esects of 13-cis-retinoic acid, all-transretinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol. 1991;96:792–797. 25. thielen a-m, saurat J-H. retinoids. in: Bolognia Jl, Jorizza Jl, schaser Jv, eds. Dermatology. 3rd ed. elsevier; 2012:2089–2103. 26. gollnick H, schramm m. topical therapy in acne. J Eur Acad Dermatol Venereol. 1998;11:s8–29. 27. kang s, krueger gg, tanghetti ea, et al. tazarotene cream in photodamage study group. a multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. J Am Acad Dermatol. 2005;52:268–274. 28. Bouloc a, vergnanini al, issa mc. a double-blind randomized study comparing the association of retinol and lr2412 with tretinoin 0.025% in photoaged skin. J Cosmet Dermatol. 2015;14:40–46. 29. dermira Presents data from drm01 Phase 2b clinical Program at annual meeting for dermatologists. 686&p=rsslanding&cat= news&id=2213702. October 21, 2016. accessed October 22, 2016. 30. dermira announces Positive topline Phase 2b clinical trial results for drm01 in Patients with Facial acne vulgaris. 686&p=irol-newsarticle&id=2166760. may 10, 2016. accessed October 22, 2016. 31. Bissonnette r, Poulin y, drew J, et al. Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: a phase iia, multicenter, randomized, vehicle controlled study. J Am Acad Dermatol. 2017;76:33–39. 32. green rs, downing dt, Pochi Pe, strauss Js. anatomical variation in the amount and composition of human skin surface lipid. J Invest Dermatol. 1970;54:240–247. 33. Hunt dwc, Hovand HeJ. drm01, a novel acetyl coenzyme a carboxylase inhibitor, reduces sebum production. J Invest Dermatol. 2014;134:s70. 34. draelos Zd, matsubara a, smiles k. the esect of 2% niacinamide on facial sebum production. J Cosmet Laser Ther. 2006;8:96–101. 35. mahmood t, akhtar n, khan Ba, et al. Outcomes of 3% green tea emulsion on skin sebum production in male volunteers. Bosn J Basic Med Sci. 2010;10:260–264. 36. mahmood t, akhtar n, moldovan c. a comparison of the esects of topical green tea and lotus on facial sebum control in healthy subjects. Hippokratis. 2013;17:64–67. 37. Peirano ri, Hamann t, dusing HJ, et al. topically applied l-carnitine esectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11:30–36. 38. gollnick H, cunlise w, Berson d, et al. management of acne: a report from a global alliance to improve Outcomes in acne. J Am Acad Dermatol. 2003;49:s1–37. 39. Hughes Br, cunlise wJ. a prospective study of the esect of isotretinoin on the follicular reservoid and sustainable sebum excretion rate in patients with acne. Arch Dermatol. 1994;130:315–318. 40. stainforth Jm, layton am, taylor JP, cunlise wJ. isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol. 1993;129:297–301. 41. cunlise wJ, layton a, knaggs He. retinoids. in: saurat JH, ed. Retinoids: 10 Years On. karger; 1991:272–280. 42. leyden JJ. the role of isotretinoin in the treatment of acne: personal observations. J Am Acad Dermatol. 1998;39:s45–49. 43. muhlemann mF, carter gO, cream JJ, wise P. Oral spironolactone: an esective treatment for acne vulgaris in women. Br J Dermatol. 1986;115:227–232. 44. Burke Bm, cunlise w. Oral spironolactone therapy

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - AUG 2017